Bristol-Myers Squibb Co
These are 3 big things we’re watching in the stock market this week
The stock market bounce last week showed once again just how dependent Wall Street has become on the whims of the White House. Case in point: The S & P 500 sank more than 2% this past Monday as President Donald Trump was attacking Federal Reserve Chairman Jerome Powell and providing scant details on tariff […]
Read More
These four stocks just entered overbought territory and could be due for a drop if volatility persists
Some stocks that investors have bought up this week could be positioned for a pullback if the market remains volatile. Stocks have seen big swings in recent weeks in reaction to the latest news about President Donald Trump’s tariffs, with investors awaiting potential deals between the U.S. and its trading partners. The president said agreements […]
Read More
Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations […]
Read More
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 […]
Read More
Stocks making the biggest moves midday: Duolingo, Tesla, Boeing, Gildan Activewear and more
Check out the companies making headlines in midday trading: Duolingo — Shares surged more than 9% following Morgan Stanley’s initiation of the language learning platform at overweight. The bank set a Wall Street-high price target on Duolingo shares and called the stock a “best-in-class consumer internet asset.” Tesla — Shares of the electric vehicle maker […]
Read More
Stocks making the biggest moves premarket: Boeing, Tesla, BP, Eli Lilly and more
Check out the companies making headlines before the bell. Boeing – The aerospace stock rose more than 5% after the company reported a narrower loss for the first quarter . Boeing said it had a net loss of $31 million in the first quarter, improving on the $355 million loss in the same period last […]
Read More
Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more
Check out the companies making headlines in extended trading: Tesla — Shares were marginally lower in extended trading after first-quarter results missed analysts’ estimates on the top and bottom lines. The electric vehicle company earned an adjusted 27 cents per share on revenue of $19.34 billion, while analysts polled by LSEG were looking for 39 […]
Read More
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
U.S. President Donald Trump speaks to the media during the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to […]
Read More
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More